Patents by Inventor Michelle J. Cannon

Michelle J. Cannon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6905884
    Abstract: The present invention relates to fluorescent cobalamins and uses of these compounds. More particularly, this invention relates to fluorescent cobalamins that comprise a fluorescent, phosphorescent, luminescent or light-producing compound covalently linked to cobalamin. These fluorescent cobalamins can be used to as diagnostic and prognostic markers (a) to distinguish cancer cells and tissues from healthy cells and tissues, including identifying lymph nodes containing cancer cells, and (b) to determine if an individual will respond positively to chemotherapy using cobalamin-therapeutic bioconjugates.
    Type: Grant
    Filed: June 15, 2004
    Date of Patent: June 14, 2005
    Assignee: University of Utah Research Foundation
    Inventors: Charles B. Grissom, Frederick G. West, James McGreevy, Joel S. Bentz, Michelle J. Cannon
  • Publication number: 20040224921
    Abstract: The present invention relates to fluorescent cobalamins and uses of these compounds. More particularly, this invention relates to fluorescent cobalamins that comprise a fluorescent, phosphorescent, luminescent or light-producing compound covalently linked to cobalamin. These fluorescent cobalamins can be used to as diagnostic and prognostic markers (a) to distinguish cancer cells and tissues from healthy cells and tissues, including identifying lymph nodes containing cancer cells, and (b) to determine if an individual will respond positively to chemotherapy using cobalamin-therapeutic bioconjugates.
    Type: Application
    Filed: June 15, 2004
    Publication date: November 11, 2004
    Applicant: University of Utah Research Foundation
    Inventors: Charles B. Grissom, Frederick G. West, James McGreevy, Joel S. Bentz, Michelle J. Cannon
  • Patent number: 6797521
    Abstract: The present invention relates to fluorescent cobalamins and uses of these compounds. More particularly, this invention relates to fluorescent cobalamins that comprise a fluorescent, phosphorescent, luminescent or light-producing compound covalently linked to cobalamin. These fluorescent cobalamins can be used to as diagnostic and prognostic markers (a) to distinguish cancer cells and tissues from healthy cells and tissues, including identifying lymph nodes containing cancer cells, and (b) to determine if an individual will respond positively to chemotherapy using cobalamin-therapeutic bioconjugates.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: September 28, 2004
    Assignee: University of Utah Research Foundation
    Inventors: Charles B. Grissom, Frederick G. West, James McGreevy, Joel S. Bentz, Michelle J. Cannon
  • Publication number: 20020192683
    Abstract: The present invention relates to fluorescent cobalamins and uses of these compounds. More particularly, this invention relates to fluorescent cobalamins that comprise a fluorescent, phosphorescent, luminescent or light-producing compound covalently linked to cobalamin. These fluorescent cobalamins can be used to as diagnostic and prognostic markers (a) to distinguish cancer cells and tissues from healthy cells and tissues, including identifying lymph nodes containing cancer cells, and (b) to determine if an individual will respond positively to chemotherapy using cobalamin-therapeutic bioconjugates.
    Type: Application
    Filed: March 15, 2002
    Publication date: December 19, 2002
    Inventors: Charles B. Grissom, Frederick G. West, James McGreevy, Joel S. Bentz, Michelle J. Cannon